Ann Arbor, MI, United States of America

Po-wai Yuen

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 390(Granted Patents)

Forward Citations (Not Self Cited) = 388(Sep 21, 2024)


Years Active: 1992-2018

where 'Filed Patents' based on already Granted Patents

40 patents (USPTO):

Title: Po-wai Yuen: Innovator in Pharmaceutical Chemistry

Introduction

Po-wai Yuen is a prominent inventor based in Ann Arbor, MI, recognized for his substantial contributions to the field of pharmaceutical chemistry. With an impressive portfolio of 40 patents, his work focuses primarily on compounds that have significant therapeutic applications.

Latest Patents

Yuen's latest patents include innovative research on triazolopyridine compounds, compositions, and their applications as Janus kinase inhibitors. These compounds are specifically outlined as Formula 0, Formula I, and Formula II, showcasing Yuen's expertise in medicinal chemistry. Additionally, he has also developed alkynyl alcohols and the methods of use for these compounds, further expanding his repertoire of impactful inventions.

Career Highlights

Throughout his career, Po-wai Yuen has worked with notable organizations, including Warner-Lambert Company and Northwestern University. His experience in these institutions has allowed him to apply his research to real-world challenges, making significant advancements in drug development.

Collaborations

Yuen has collaborated with several esteemed professionals in his field, including Richard B. Silverman and Ryszard Andruszkiewicz. These collaborations have been instrumental in driving innovation and enhancing the quality of pharmaceutical research and development.

Conclusion

With his extensive number of patents and collaborative efforts, Po-wai Yuen continues to be an influential figure in the realm of drug discovery and development. His work not only exemplifies innovation in pharmaceutical chemistry but also contributes to better health solutions for society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…